InvestorsHub Logo
Followers 79
Posts 24611
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Wednesday, 03/20/2024 7:38:59 AM

Wednesday, March 20, 2024 7:38:59 AM

Post# of 27525
NLSP - .2694 Pre-market at .417/419

NLS Pharmaceutics Secures Exclusive Global License for Next-Generation Non-Sulfonamide Dual Orexin Agonist Platform

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.